From Penny Stocks to Large-Cap: $25,000 Funded Trader George F. Shares His Journey
Note sull'episodio
Welcome to another Trade The Pool funded trader interview. Today, Michael sits down with George F., a FLEX $25,000 funded trader from the USA!
George shares how he transitioned from scalping volatile penny stocks to focusing on mid to large-cap stocks like Halozyme Therapeutics ($HALO) using Trade The Pool’s stock-focused, Limited Risk proprietary trading platform.
He opens up about his six-year trading journey, starting in college with FDA-linked penny stocks, overcoming inconsistent profits, and adapting to large cap strategies to pass the FLEX 25K evaluation. His disciplined approach, together with his mentorship, helped him achieve a 43% success rate and a 1:3.7 risk/reward ratio.
View George's statistics: FLEX $25K evaluation summary
George started as a health care provider. He began trading in 2018, initially shorting penny stocks tied to FDA calendar. Early struggles with small capital and volatile low floats challenged his consistency until he joined a trading community during a bear market.
In 2024, guided by his cousin and a mentor, he shifted to large-cap stocks, targeting same-day earnings plays with opening range breakouts and VWAP/9 EMA reversions. By embracing Trade The Pool’s risk parameters and sim trading, he passed the $25K FLEX evaluation, proving that transitioning from a brokerage account to a prop firm is indeed achievable.
George's evaluation stats:
- Halozyme Therapeutics, Inc. ($HALO)
- Success rate: 43%
- Risk/Reward ratio: 1:3.7
- Biggest win: +$407, long on $HALO x 250 shares
- Biggest loss: -$226, long on $TWLO x 200 shares
Do you have what it takes to become a Trade The Pool funded trader?
► Follow us!
Website: https://tradethepool.com/
Instagram: https://www.instagram.com/tradethepool
X/Twitter: https://twitter.com/tradethepool
Facebook: https://www.facebook.com/trade.the.pool